Yazdan Rahmati

457 total citations
19 papers, 333 citations indexed

About

Yazdan Rahmati is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Yazdan Rahmati has authored 19 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Yazdan Rahmati's work include MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (5 papers). Yazdan Rahmati is often cited by papers focused on MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (5 papers). Yazdan Rahmati collaborates with scholars based in Iran, Malaysia and Singapore. Yazdan Rahmati's co-authors include Shahram Teimourian, Sajad Najafi, Shahin Aghamiri, Yahya Asemani, Mohammad Reza Alivand, Shing Cheng Tan, Pourya Raee, Fatemeh Ezzatifar, Javid Sadri Nahand and Vahid Jajarmi and has published in prestigious journals such as Biomedicine & Pharmacotherapy, Cancer Chemotherapy and Pharmacology and Immunobiology.

In The Last Decade

Yazdan Rahmati

18 papers receiving 331 citations

Peers

Countries citing papers authored by Yazdan Rahmati

Since Specialization

Citations

This map shows the geographic impact of Yazdan Rahmati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yazdan Rahmati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yazdan Rahmati more than expected).

Fields of papers citing papers by Yazdan Rahmati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yazdan Rahmati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yazdan Rahmati. The network helps show where Yazdan Rahmati may publish in the future.

Co-authorship network of co-authors of Yazdan Rahmati

This figure shows the co-authorship network connecting the top 25 collaborators of Yazdan Rahmati. A scholar is included among the top collaborators of Yazdan Rahmati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yazdan Rahmati. Yazdan Rahmati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Title	Journal	Authors	Indexed citations
1	Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections	Biomedicine & Pharmacotherapy	Sajad Najafi, Shing Cheng Tan et al.	48
2	Circular RNAs as novel biomarkers in triple-negative breast cancer: a systematic review	Molecular Biology Reports	Mohammad Zaefizadeh, Yazdan Rahmati et al.	4
3	Hsa-miR-19b-3p and Hsa-miR-23b-3P are the candidate biomarkers for bipolar disorder	Informatics in Medicine Unlocked	Payam Mohammadi, Mohammad Reza Alivand et al.	1
4	MiR-574-5P, miR-1827, and miR-4429 as Potential Biomarkers for Schizophrenia	Journal of Molecular Neuroscience	Sajad Najafi, Hossein Zhaleh et al.	25
5	MiR-330-3p and miR-485-5p as biomarkers for glioblastoma: An integrated bioinformatics and experimental study	Computational Biology and Chemistry	Yazdan Rahmati, Mohammad Reza Alivand et al.	6
6	The related miRNAs involved in doxorubicin resistance or sensitivity of various cancers: an update	Cancer Chemotherapy and Pharmacology	Yazdan Rahmati, Majid Pornour et al.	13
7	CiRS-7/CDR1as; An oncogenic circular RNA as a potential cancer biomarker	Pathology - Research and Practice	Yazdan Rahmati, Yahya Asemani et al.	36
8	Integrative analysis of DNA methylation and gene expression profiles to identify biomarkers of glioblastoma	Cancer Genetics	Mohammad Reza Alivand, Sajad Najafi et al.	14
9	CASP5 and CR1 as potential biomarkers for Kawasaki disease: an Integrated Bioinformatics-Experimental Study	BMC Pediatrics	Yazdan Rahmati, Sajad Najafi et al.	3
10	Gene regulation by antisense transcription: A focus on neurological and cancer diseases	Biomedicine & Pharmacotherapy	Sajad Najafi, Shing Cheng Tan et al.	46
11	The expression of miR-513c and miR-3163 was downregulated in tumor tissues compared with normal adjacent tissue of patients with breast cancer	BMC Medical Genomics	Yazdan Rahmati, Farhad Seif et al.	18
12	The role of IDH1 mutation on gene expression in glioblastoma	Informatics in Medicine Unlocked	Sajad Najafi, Hossein Zhaleh et al.	4
13	Promising therapeutic approaches using CRISPR/Cas9 genome editing technology in the treatment of Duchenne muscular dystrophy	Genes & Diseases	Yazdan Rahmati, Shahram Teimourian et al.	25
14	Exploring Kawasaki disease-specific hub genes revealing a striking similarity of expression profile to bacterial infections using weighted gene co-expression network analysis (WGCNA) and co-expression modules identification tool (CEMiTool): An integrated bioinformatics and experimental study	Immunobiology	Yazdan Rahmati et al.	8
15	Identification of 7 key age-related genes involved in Kawasaki disease, an integrated study by metaDE and weighted gene co-expression network analysis		Yazdan Rahmati et al.	1
16	Gene expression analysis in Kawasaki disease; bioinformatics and experimental approach	Informatics in Medicine Unlocked	Yazdan Rahmati, Alireza Nateghian et al.	7
17	Screening the underlying molecular mechanisms involved in the development of heart failure	Meta Gene	Yazdan Rahmati, Shahram Teimourian et al.	1
18	CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment	Human Immunology	Yazdan Rahmati, Shahram Teimourian et al.	73
19	Methylation Status of NANOG1, RASSF1A, SFN, CASP8, WIF1,CTSL2 Genes in Iranian Breast Cancer Patients		Ali M. Ardekani, Seyed Ahmad Hashemi et al.	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact